Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-987-2 | CAS number: 1241-94-7
Oral (feeding) 90-d repeated dose toxicity study (equivalent to OECD408): NOAEL 7.3 mg/kg bw/day
The effects of repeated exposure to 2EHDPP are investigated in two studies. Both studies report hypertrophy of the liver as key finding. In addition it seems that the palatability of the test substance influences feed intake to some extent. The authors attribute the effects on body weight and water intake to the effect on food intake. However, this cannot be fully excluded. The effect on liver weight and histopathological findings cannot be relate to reduced food intake only. Therefore, based on the full BIBRA study it is not possible to derive a NOAEL as the liver effects were also seen at the lowest dose level tested. This study leads to a LOAEL of 164-174 mg/kg bw. This LOAEL is in line with the LOAEL parental coming from the one generation study where similar liver effects were reported. In the one generation study, the effects on relative liver weight were supported by histopatological examination in the high dose group only. Absence of histopathological data for the other groups makes it impossible to derive a parental NOAEL. Therefore the LOAEL parental is set at 132-144 mg/kg bw which is the lowest dose level.
For the selected key study for repeated dose toxicity only an abstract is available. This study is a 90 -day study that addresses the liver effects in more detail (NB it is a full 90 -day study). In this study effects on liver and liver enzymes are reported at a dose level of 17-20 mg/kg bw in males. For females, effects are observed only at 20.8 mg/kg bw. The NOAEL is set at 7.3-8.4 mg/kg bw based on these effects in males.
In addition, a 12 -d repeated dose toxicity is available in which 12 female rats were given 10000 mg/kg bw/day for 12 days by oral gavage. 12 male rats received 5000 mg/kg bw/day. Under the conditions of this study, treatment with Santicizer 141 only induced weight loss and some minor clinical signs. No NOAEL could be identified.
Another supporting study is available, which was a long-term repeated dose toxicity study in dogs. Two doses were tested: 0.5 ml/kg bw/day and 1 ml/kg bw/day. Dogs of the high dose group were found to have a decreased body weight over the treatment period. No other adverse effects were identified (including gross necropsy/histopathology) after chronic exposure.
Based on the available data, no conclusion can be drawn considering the classification for repeated dose toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again